Jimmie Joe, I think that you will find that most of us who are behind this investment but who are often critical of management (like myself) are not questioning the science or the procedures involved with running a biotech company. I think that the disatisfaction comes from feeling out of touch with the progress of the science and the feeling of vulnerability concerning the company's finances. Poor public relations is the problem here, not the future of synDNA if it turns out to be all we want it to be.
I appreciate your knowledge of biotech operations and the contributions of other posters who understand medicine and the biotech arena better than I, but I stand firm in my opinion that the company could be better managed. As I have alluded to in previous posts, I would be happier and more supportive of management if I could feel confident that the company can get the financing it needs in the proper way and if I had a clue as to the timetable for success (within a year say).
The info I was getting from the company came through a broker who said he was getting info from financial management at CYGX. I then proceeded to make an ass of myself by posting what I had heard on this board (i.e. agriculture, China, etc.) only to find out later that it was either baloney or way in advance of the potential deals. The info I was getting also came at a time that the company was "quietly" promoting PPOs. Hello!?
I sincerely hope that CYGX's management can reinvent itself to address my two major concerns or I will take your advice JJ and bail on the last business day of the year. Have a happy Turkey Day!
